Tariffs

News

AbbVie makes its tariffs-driven investment play

AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the Trump administration.

News

MSD has gauged its financial hit from Trump tariffs

MSD expects to see an additional $200m layered onto its costs this year as a result of President Trump's tariffs, ahead of any pharma-specific levy.

News

Roche seeking talks with the US on tariff exemptions

Roche is petitioning the US administration for an exemption from tariffs for pharmaceuticals, arguing there is no trade imbalance in its US business.

News

Roche joins the pharma firms planning big US investments

Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports.

News

Tariffs spelled out with Scrabble letters

Tariffs 'could cancel out discounts with biosimilars'

Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.

News

J&J expecting $400m hit from tariffs in 2025

J&J chief executive Joaquin Duato has told analysts that tax policy, not tariffs, is the key to increasing pharma manufacturing capacity in the US.

AbbVie makes its tariffs-driven investment play

MSD has gauged its financial hit from Trump tariffs

Roche seeking talks with the US on tariff exemptions

Roche joins the pharma firms planning big US investments

Tariffs 'could cancel out discounts with biosimilars'

J&J expecting $400m hit from tariffs in 2025

Doctors dismayed by report of NHS AI proposal

Discover a new era of healthcare panel engagement: Grounded ...

Tariffs

Editor's Picks